Organigram Global Inc. (OGI) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello, everyone. Thank you for joining us and welcome to the Organigram Global Q1 Fiscal 2026 Earnings Call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star 1 on your telephone keypad. To withdraw your question, press star 1 again. I will now hand the call over to Max Schwartz, Director of Investor Relations. Please go ahead. Thank you very much, Cara, and good morning, everyone. Thanks for joining us today. As a brief reminder, this call is being recorded and a replay will be available on our website within 24 hours. Today's call will include forward-looking information, forward-looking statements, and actual results could differ materially due to a number of risk factors outlined in our filings and the cautionary statements included in our Q1 fiscal 2026 press release and MD&A. We'll also reference certain non-IFRS measures, such as adjusted EBITDA, adjusted gross margin, and free cash flow. Definitions and reconciliations are available in our disclosed materials. Unless otherwise noted, market share data is sourced from high-fire, weed-crawler provincial boards, retailers, and our own internal sales tracking. Discussing results today are James Yamanaka, CEO of Organigram, and Greg Dyett, CFO of Organigram Global. And as a reminder, any investor inquiries not addressed on today's call can be directed to investors at Organigram.ca. And with that, I'll now turn the call over to James. Please go ahead, James. Thank you, Max, and good morning, everyone. Thanks for joining us today. This is my first earnings call as CEO of Organigram, and I've been encouraged by what I've seen so far. The scale of our operations, the quality of the team, and the depth of capability across the business mak...